Skip to content
About
About us
Our Capabilities
Our Facility
Our Team
Work at IDT
Advanced Therapies
Aseptic Fill & Finish
mRNA – ADCs
Specialty Orals
Psychedelics/Medicinal Cannabis
Oral Finished Dose
API & Intermediates
Active Pharmaceutical Ingredients
Investors
ASX Announcements
Share Price
Corporate Governance
Investor Presentations
Annual Reports
News
Contact
News
Home
»
News
»
IDT appoints Michael Kotsanis as non-executive Director
IDT appoints Michael Kotsanis as non-executive Director
April 9, 2020
|
News
The announcement can be viewed
here
:
Posts navigation
← Appendix 2A
Appendix 2A →
